NEW YORK/PARIS, Jan 31 (Reuters) - French drugmaker Sanofi sued Eli Lilly and Co for alleged patent infringements concerning its top-selling Lantus diabetes treatment, delaying the U.S. company's plans to produce its own version of the drug.
Read more here >>
Reuters |
Quails
